{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:39:09Z","timestamp":1792931949434,"version":"4.5.0"},"reference-count":67,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,11]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Chromosomal rearrangements that generate novel fusion genes are a hallmark of acute myeloid leukemia (AML). Depletion experiments in cell line models have suggested that their continued expression is required for maintaining their leukemic phenotype and that fusion genes therefore represent ideal cancer-specific therapeutic targets. However, the extent to which this result holds true for the different stages of hematopoietic development in primary cells and whether therapeutic agents can be efficiently delivered to those cells is still unclear. In this study, we demonstrate that primary AML cells harboring the chromosomal translocation t(8;21) are critically dependent on the corresponding fusion gene, RUNX1::RUNX1T1, to suppress differentiation and maintain stemness. Silencing RUNX1::RUNX1T1 expression using small interfering RNA (siRNA)\u2013loaded lipid nanoparticles induces substantial changes in chromatin accessibility, thereby redirecting the leukemia-associated transcriptional network toward a myeloid differentiation program. Single-cell analyses reveal that this transcriptional reprogramming is associated with the depletion of immature stem and progenitor-like cell populations, accompanied by an expansion of granulocytic and eosinophilic\/mast cell\u2013like populations with impaired self-renewal capacity. These findings underscore the essential role of RUNX1::RUNX1T1 in sustaining AML and highlight the therapeutic potential of targeting fusion gene expression in primary AML cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025028988","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:56:12Z","timestamp":1758740172000},"page":"2963-2978","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Fusion gene depletion eliminates stemness and induces bidirectional differentiation of acute myeloid leukemia"],"prefix":"10.1182","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-7378","authenticated-orcid":false,"given":"Polina K.","family":"Derevyanko","sequence":"first","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Swart","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Daniel","family":"Mata Casimiro","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"van Oort","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4375-5695","authenticated-orcid":false,"given":"Manisha","family":"du Plessis","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"van den Brink","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6991-8587","authenticated-orcid":false,"given":"Minoo","family":"Ashtiani","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michel","family":"Zwaan","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"2Department of Pediatric Hematology\/Oncology, Erasmus MC Sophia Children\u2019s Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1927-9286","authenticated-orcid":false,"given":"Anja","family":"Krippner-Heidenreich","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-0825","authenticated-orcid":false,"given":"Constanze","family":"Bonifer","sequence":"additional","affiliation":[{"name":"3Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom"},{"name":"4Murdoch Children\u2019s Research Institute, The Royal Children\u2019s Hospital, Parkville, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Schiffelers","sequence":"additional","affiliation":[{"name":"5Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1825-1890","authenticated-orcid":false,"given":"Josef","family":"Vormoor","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie G.","family":"Kellaway","sequence":"additional","affiliation":[{"name":"6Blood Cancer and Stem Cells, Centre for Cancer Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5404-6483","authenticated-orcid":false,"given":"Olaf","family":"Heidenreich","sequence":"additional","affiliation":[{"name":"1Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"7Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands"},{"name":"8Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2025121111220741300_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MOP.0000000000000855","article-title":"Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy","volume":"32","author":"Elgarten","year":"2020","journal-title":"Curr Opin Pediatr"},{"issue":"12","key":"2025121111220741300_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2025121111220741300_bib3","doi-asserted-by":"crossref","first-page":"e28979","DOI":"10.1002\/pbc.28979","article-title":"Treatment of acute myeloid leukemia in children: a practical perspective","volume":"68","author":"Egan","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2025121111220741300_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41408-023-00954-z","article-title":"Time independent factors that predict relapse in adults with acute myeloid leukemia","volume":"14","author":"Lim","year":"2024","journal-title":"Blood Cancer J"},{"issue":"8","key":"2025121111220741300_bib5","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1038\/s41375-022-01619-9","article-title":"Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies","volume":"36","author":"Zarnegar-Lumley","year":"2022","journal-title":"Leukemia"},{"issue":"3","key":"2025121111220741300_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/jcm11030504","article-title":"Pediatric acute myeloid leukemia-past, present, and future","volume":"11","author":"Reinhardt","year":"2022","journal-title":"J Clin Med"},{"issue":"10","key":"2025121111220741300_bib7","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/cancers13102336","article-title":"Survival following relapse in children with acute myeloid leukemia: a report from AML-BFM and COG","volume":"13","author":"Rasche","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2025121111220741300_bib8","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"issue":"12","key":"2025121111220741300_bib9","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.febslet.2010.04.002","article-title":"The molecular signature of oncofusion proteins in acute myeloid leukemia","volume":"584","author":"Martens","year":"2010","journal-title":"FEBS Lett"},{"issue":"24","key":"2025121111220741300_bib10","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1002\/cncr.30220","article-title":"Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups","volume":"122","author":"Creutzig","year":"2016","journal-title":"Cancer"},{"issue":"12","key":"2025121111220741300_bib11","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1517\/14712598.4.12.1921","article-title":"RNA interference as a potential tool in the treatment of leukaemia","volume":"4","author":"Borkhardt","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"2025121111220741300_bib12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3324\/haematol.2009.008359","article-title":"Longitudinal growth retardation in a prepuberal girl with chronic myeloid leukemia on long-term treatment with imatinib","volume":"94","author":"Schmid","year":"2009","journal-title":"Haematologica"},{"issue":"7","key":"2025121111220741300_bib13","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1002\/j.1460-2075.1993.tb05933.x","article-title":"The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript","volume":"12","author":"Miyoshi","year":"1993","journal-title":"EMBO J"},{"issue":"8","key":"2025121111220741300_bib14","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1182\/blood-2002-05-1589","article-title":"AML1\/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells","volume":"101","author":"Heidenreich","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2025121111220741300_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ccell.2018.08.015","article-title":"The oncogenic transcription factor RUNX1\/ETO corrupts cell cycle regulation to drive leukemic transformation","volume":"34","author":"Martinez-Soria","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"2025121111220741300_bib16","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2014.08.024","article-title":"Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal","volume":"8","author":"Ptasinska","year":"2014","journal-title":"Cell Rep"},{"issue":"11","key":"2025121111220741300_bib17","doi-asserted-by":"crossref","first-page":"e1000275","DOI":"10.1371\/journal.pgen.1000275","article-title":"AML1\/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets","volume":"4","author":"Gardini","year":"2008","journal-title":"PLoS Genet"},{"issue":"10","key":"2025121111220741300_bib18","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2005-03-1283","article-title":"Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells","volume":"106","author":"Thomas","year":"2005","journal-title":"Blood"},{"issue":"4","key":"2025121111220741300_bib19","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2002-06-1685","article-title":"Specific inhibition of bcr-abl gene expression by small interfering RNA","volume":"101","author":"Scherr","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2025121111220741300_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood-2013-09-525741","article-title":"MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia","volume":"124","author":"Manara","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2025121111220741300_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/leu.2017.269","article-title":"RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo","volume":"32","author":"Jyotsana","year":"2018","journal-title":"Leukemia"},{"issue":"4","key":"2025121111220741300_bib22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41375-023-01854-8","article-title":"Nanoparticle-mediated targeting of the fusion gene RUNX1\/ETO in t(8;21)-positive acute myeloid leukaemia","volume":"37","author":"Issa","year":"2023","journal-title":"Leukemia"},{"key":"2025121111220741300_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jconrel.2024.02.018","article-title":"Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models","volume":"367","author":"Ansari","year":"2024","journal-title":"J Control Release"},{"issue":"1","key":"2025121111220741300_bib24","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41467-024-45691-4","article-title":"Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth","volume":"15","author":"Kellaway","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"2025121111220741300_bib25","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/pharmaceutics15061603","article-title":"Increased bone marrow uptake and accumulation of very-late antigen-4 targeted lipid nanoparticles","volume":"15","author":"Swart","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"2025121111220741300_bib26","doi-asserted-by":"crossref","first-page":"100717","DOI":"10.1016\/j.xcrm.2022.100717","article-title":"hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia","volume":"3","author":"Pal","year":"2022","journal-title":"Cell Rep Med"},{"key":"2025121111220741300_bib27","doi-asserted-by":"crossref","first-page":"121741","DOI":"10.1016\/j.ijpharm.2022.121741","article-title":"A robust post-insertion method for the preparation of targeted siRNA LNPs","volume":"620","author":"Swart","year":"2022","journal-title":"Int J Pharm"},{"issue":"52","key":"2025121111220741300_bib28","doi-asserted-by":"crossref","first-page":"48670","DOI":"10.1074\/jbc.M103194200","article-title":"Real time analysis of the affinity regulation of alpha 4-integrin. The physiologically activated receptor is intermediate in affinity between resting and Mn(2+) or antibody activation","volume":"276","author":"Chigaev","year":"2001","journal-title":"J Biol Chem"},{"issue":"8","key":"2025121111220741300_bib29","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/leu.2012.49","article-title":"Depletion of RUNX1\/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding","volume":"26","author":"Ptasinska","year":"2012","journal-title":"Leukemia"},{"issue":"19","key":"2025121111220741300_bib30","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1038\/sj.onc.1210940","article-title":"C\/EBP alpha:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C\/EBP alpha homodimers or AP-1","volume":"27","author":"Cai","year":"2008","journal-title":"Oncogene"},{"issue":"4","key":"2025121111220741300_bib31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12185-015-1764-6","article-title":"C\/EBP\u03b1 in normal and malignant myelopoiesis","volume":"101","author":"Friedman","year":"2015","journal-title":"Int J Hematol"},{"issue":"22","key":"2025121111220741300_bib32","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1002\/1873-3468.12343","article-title":"Chromatin programming by developmentally regulated transcription factors: lessons from the study of haematopoietic stem cell specification and differentiation","volume":"590","author":"Obier","year":"2016","journal-title":"FEBS Lett"},{"issue":"1","key":"2025121111220741300_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41588-018-0270-1","article-title":"Subtype-specific regulatory network rewiring in acute myeloid leukemia","volume":"51","author":"Assi","year":"2019","journal-title":"Nat Genet"},{"issue":"15","key":"2025121111220741300_bib34","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2016-09-687822","article-title":"Expression and regulation of C\/EBP\u03b1 in normal myelopoiesis and in malignant transformation","volume":"129","author":"Avellino","year":"2017","journal-title":"Blood"},{"issue":"12","key":"2025121111220741300_bib35","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1073\/pnas.94.12.6462","article-title":"CCAAT\/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing","volume":"94","author":"Yamanaka","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2025121111220741300_bib36","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2003-02-0477","article-title":"Transcription activation function of C\/EBPalpha is required for induction of granulocytic differentiation","volume":"102","author":"Keeshan","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2025121111220741300_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/86515","article-title":"AML1-ETO downregulates the granulocytic differentiation factor C\/EBPalpha in t(8;21) myeloid leukemia","volume":"7","author":"Pabst","year":"2001","journal-title":"Nat Med"},{"issue":"23","key":"2025121111220741300_bib38","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1182\/blood.2018886077","article-title":"Identification of a novel enhancer of CEBPE essential for granulocytic differentiation","volume":"133","author":"Shyamsunder","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2025121111220741300_bib39","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1038\/s41467-022-31332-1","article-title":"Transcription factor-driven coordination of cell cycle exit and lineage-specification in vivo during granulocytic differentiation : in memoriam Professor Niels Borregaard","volume":"13","author":"Theilgaard-M\u00f6nch","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"2025121111220741300_bib40","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1038\/sj.leu.2404961","article-title":"Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia","volume":"21","author":"Tonks","year":"2007","journal-title":"Leukemia"},{"key":"2025121111220741300_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exphem.2018.09.004","article-title":"The Human Cell Atlas bone marrow single-cell interactive web portal","volume":"68","author":"Hay","year":"2018","journal-title":"Exp Hematol"},{"issue":"45","key":"2025121111220741300_bib42","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1038\/sj.onc.1209638","article-title":"siRNA-mediated AML1\/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts","volume":"25","author":"Dunne","year":"2006","journal-title":"Oncogene"},{"issue":"12","key":"2025121111220741300_bib43","doi-asserted-by":"crossref","first-page":"e0225977","DOI":"10.1371\/journal.pone.0225977","article-title":"Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of cathepsin G and neutrophil elastase","volume":"14","author":"Schoenherr","year":"2019","journal-title":"PLoS One"},{"key":"2025121111220741300_bib44","doi-asserted-by":"crossref","first-page":"101308","DOI":"10.1016\/j.smim.2019.101308","article-title":"VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity","volume":"42","author":"ElTanbouly","year":"2019","journal-title":"Semin Immunol"},{"issue":"4","key":"2025121111220741300_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/2643-3230.BCD-24-0342","article-title":"Single-cell transcriptional atlas of human hematopoiesis reveals genetic and hierarchy-based determinants of aberrant AML differentiation","volume":"6","author":"Zeng","year":"2025","journal-title":"Blood Cancer Discov"},{"issue":"4","key":"2025121111220741300_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ajh.10176","article-title":"Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development","volume":"71","author":"Elghetany","year":"2002","journal-title":"Am J Hematol"},{"issue":"7769","key":"2025121111220741300_bib47","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"issue":"12","key":"2025121111220741300_bib48","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ccell.2023.10.008","article-title":"A longitudinal single-cell atlas of treatment response in pediatric AML","volume":"41","author":"Lambo","year":"2023","journal-title":"Cancer Cell"},{"issue":"6859","key":"2025121111220741300_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"Reya","year":"2001","journal-title":"Nature"},{"issue":"5","key":"2025121111220741300_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.molonc.2010.06.001","article-title":"Targeting leukemic stem cells by breaking their dormancy","volume":"4","author":"Essers","year":"2010","journal-title":"Mol Oncol"},{"issue":"3","key":"2025121111220741300_bib51","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41375-019-0604-8","article-title":"A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia","volume":"34","author":"Elsayed","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"2025121111220741300_bib52","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molcel.2020.12.005","article-title":"Definition of a small core transcriptional circuit regulated by AML1-ETO","volume":"81","author":"Stengel","year":"2021","journal-title":"Mol Cell"},{"issue":"7","key":"2025121111220741300_bib53","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"issue":"3","key":"2025121111220741300_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","article-title":"Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence","volume":"34","author":"Boyd","year":"2018","journal-title":"Cancer Cell"},{"issue":"2","key":"2025121111220741300_bib55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.stem.2019.07.001","article-title":"Interconversion between tumorigenic and differentiated states in acute myeloid leukemia","volume":"25","author":"McKenzie","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2025121111220741300_bib56","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2159-8290.CD-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"issue":"6","key":"2025121111220741300_bib57","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","article-title":"Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"2025121111220741300_bib58","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1038\/s41467-021-26849-w","article-title":"Acute myeloid leukemia maturation lineage influences residual disease and relapse following differentiation therapy","volume":"12","author":"Ngo","year":"2021","journal-title":"Nat Commun"},{"issue":"5997","key":"2025121111220741300_bib59","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"issue":"4","key":"2025121111220741300_bib60","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nmeth.2847","article-title":"Identification of small molecules that support human leukemia stem cell activity ex vivo","volume":"11","author":"Pabst","year":"2014","journal-title":"Nat Methods"},{"issue":"10","key":"2025121111220741300_bib61","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood.2023021342","article-title":"KBTBD4-mediated reduction of MYC is critical for hematopoietic stem cell expansion upon UM171 treatment","volume":"143","author":"Chagraoui","year":"2024","journal-title":"Blood"},{"issue":"11","key":"2025121111220741300_bib62","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.leukres.2012.07.001","article-title":"Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis","volume":"36","author":"Cornet","year":"2012","journal-title":"Leuk Res"},{"issue":"11","key":"2025121111220741300_bib63","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.leukres.2013.08.010","article-title":"Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1","volume":"37","author":"Pullarkat","year":"2013","journal-title":"Leuk Res"},{"issue":"5","key":"2025121111220741300_bib64","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood.2024024264","article-title":"Fusion-harboring mast cells can explain molecular positivity in flow cytometric MRD-negative core-binding factor AML","volume":"144","author":"Cook","year":"2024","journal-title":"Blood"},{"issue":"suppl 1","key":"2025121111220741300_bib65","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1182\/blood-2024-199996","article-title":"Presence of leukemia-related basophils and mast cells with atypical immunophenotype during induction should not be interpreted as measurable residual disease in children with acute myeloid leukemia with RUNX1::RUNX1T1 [abstract]","volume":"144","author":"Soboli","year":"2024","journal-title":"Blood"},{"issue":"21","key":"2025121111220741300_bib66","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1101\/gad.1493506","article-title":"The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages","volume":"20","author":"Iwasaki","year":"2006","journal-title":"Genes Dev"},{"issue":"10","key":"2025121111220741300_bib67","doi-asserted-by":"crossref","first-page":"e2317147121","DOI":"10.1073\/pnas.2317147121","article-title":"Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program","volume":"121","author":"Katsumura","year":"2024","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/24\/2963\/2471140\/blood_bld-2025-028988-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/24\/2963\/2471140\/blood_bld-2025-028988-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T16:22:21Z","timestamp":1765470141000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/24\/2963\/547449\/Fusion-gene-depletion-eliminates-stemness-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":67,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025,12,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025028988","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,11]]},"published":{"date-parts":[[2025,12,11]]}}}